US Patent 7906507 Oxadiazoanthracene compounds for the treatment of diabetes
Patent 7906507 was granted and assigned to TransTech Pharma on March, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 27 Nov, 2023
Golden AI
Edits made to:
Article (+160 characters)
Article
Patent abstract
The present invention provides methods of use of oxadiazoanthracene derivatives of the formula (I) and pharmaceutically acceptable salts thereof,
Edits on 19 Sep, 2023
Golden AI
Edits made to:
Infobox (+7 properties)
Infobox
Patent Inventor Names
Adnan M. M. Mjalli0
Christopher Behme0
Dharma Rao Polisetti0
Kalpathy Santhosh0
Mustafa Guzel0
Stephen Thomas Davis0
Thomas Scott Yokum0
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07906507 Oxadiazoanthracene compounds for the treatment of diabetes US Patent 7906507 Oxadiazoanthracene compounds for the treatment of diabetes
Infobox
Patent Number
07906507
Patent Number
7906507
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 4 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 7 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07906507 Oxadiazoanthracene compounds for the treatment of diabetes
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07906507
Date of patent
March 15, 2011
Patent application number
12849225
Date Filed
August 3, 2010
Patent primary examiner
Find more entities like US Patent 7906507 Oxadiazoanthracene compounds for the treatment of diabetes
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
